Source: IMARC Group | Category: Healthcare
Report Introduction
According to IMARC Group’s latest report titled "India Continuous Glucose Monitoring Devices Market Size, Share, Trends and Forecast by Component, and Region, 2026-2034", this study offers a granular analysis of the nation's diabetes management landscape. This research report offers a profound analysis of the industry, encompassing market share, size, India CGM Devices market growth factors, key trends, and regional insights. The report covers critical market dynamics, including the shift from traditional finger-prick testing to real-time monitoring, the integration of AI-driven health analytics, and the increasing accessibility of CGMs through local manufacturing initiatives under "Make in India".
Market At-A-Glance: Key Statistics (2026-2034):
- Current Market Size (2025): USD 240.6 Million
- Projected Market Size (2034): USD 359.41 Million
- Growth Rate (CAGR): 4.56%
- Dominant Region: North India (Driven by high diabetes prevalence and advanced healthcare infrastructure in Delhi-NCR).
Request a Business Sample Report for Procurement & Investment Evaluation
India Continuous Glucose Monitoring Devices Market Overview
The India continuous glucose monitoring devices market size reached USD 240.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 359.41 Million by 2034, exhibiting a steady growth rate (CAGR) of 4.56% during 2026-2034.
The market is witnessing a paradigm shift in diabetes care, driven by the country's status as the "Diabetes Capital of the World." The transition from reactive management to proactive, real-time glucose tracking is accelerating, supported by the launch of affordable, factory-calibrated sensors. Hospitals and endocrinologists are increasingly prescribing CGMs not just for Type 1 diabetes patients but also for Type 2 patients to better manage glycemic variability. Furthermore, the integration of these devices with smartphones and cloud platforms allows for remote patient monitoring, a trend that gained immense traction post-pandemic and is now becoming standard practice in urban healthcare settings.
Top Emerging Trends in the India Continuous Glucose Monitoring Devices Market:
- Increasing adoption of continuous glucose monitoring devices for real-time diabetes management is transforming patient care, enabling continuous tracking, reducing finger-prick dependency, and improving glycemic control outcomes across India.
- Rapid integration of CGM devices with smartphones and digital health platforms is enhancing user experience, enabling remote monitoring, data analytics, and personalized treatment decisions through connected healthcare ecosystems.
- Growing shift toward home-based diabetes management is emerging as a key trend, with patients preferring convenient, self-monitoring solutions supported by easy-to-use wearable sensors and increasing awareness of proactive health management.
- Advancements in sensor technologies and minimally invasive devices are improving accuracy, wearability, and lifespan of CGM systems, encouraging wider adoption across diverse patient groups and healthcare providers.
- Increasing focus on integrated CGM-insulin pump systems is gaining traction, enabling automated insulin delivery and better disease management, particularly among patients requiring intensive diabetes care and continuous monitoring solutions.
India Continuous Glucose Monitoring Devices Market Growth Factors (Drivers)
- Rising prevalence of diabetes in India, with over 100 million affected individuals, is significantly driving demand for advanced glucose monitoring solutions, creating strong growth opportunities for CGM device manufacturers.
- Strong market growth trajectory, with projections indicating double-digit CAGR up to 2033, is attracting investments and encouraging innovation in continuous glucose monitoring technologies across the healthcare sector.
- Increasing awareness regarding early diagnosis and continuous monitoring of blood glucose levels is boosting adoption, as patients and healthcare providers focus on preventive care and improved disease management outcomes.
- Expansion of healthcare infrastructure and government-led initiatives supporting diabetes management are improving access to advanced monitoring devices, strengthening overall market penetration across urban and semi-urban regions.
- Rising adoption of digital health technologies and telemedicine platforms is supporting CGM demand, enabling remote patient monitoring, data-driven treatment decisions, and enhanced connectivity between patients and healthcare providers.
Market Segmentation
Analysis by Component:
- Sensors (Dominant segment due to recurring usage)
- Durables (Receivers and Transmitters)
Regional Insights:
- North India (Highest market share due to healthcare infrastructure)
- West and Central India
- South India
- East India
India Continuous Glucose Monitoring Devices Market Recent Developments & News
- August 2025: Abbott launched the FreeStyle Libre 2 Plus in India, offering real-time glucose monitoring with optional alarms for better safety.
- June 2025: Tracky introduced India's first Bluetooth-enabled continuous glucose monitoring device, enhancing accessibility with a scan-free mobile app experience.
- Strategic Partnerships: Global medical technology companies are collaborating with local players to introduce climate-suitable and affordable CGM solutions.
Why Buy This Report? (High-Value Insights)
- Granular Segmentation: Detailed analysis of Sensor vs. Transmitter revenue streams, helping distributors manage inventory cycles effectively.
- Regional Hotspots: In-depth breakdown of demand in Tier-1 vs. Tier-2 cities, identifying the next wave of adoption beyond the metros.
- Future-Ready Trends: Insights into the commercial viability of Non-Invasive Glucose Monitoring, highlighting the next frontier of R&D.
Key Highlights of the Report
- Market Forecast (2026-2034): Quantitative data on market value and steady growth trajectory.
- Competitive Landscape: Comprehensive analysis of global giants versus emerging Indian startups.
- Strategic Analysis: Porter’s Five Forces analysis and value chain assessment.
- Technological Trends: Insights into advancements in sensor enzyme technology for better accuracy.
Ask Analyst for Custom Research Report
Customization Note: If you require specific data we can provide it as part of our customization services.
Frequently Asked Questions (FAQs)
Q1: What is the projected size and growth rate of the India CGM Devices Market?
Answer: The India CGM Devices Market was valued at USD 240.6 Million in 2025 and is projected to reach USD 359.41 Million by 2034, growing at a steady Compound Annual Growth Rate (CAGR) of 4.56% during the forecast period.
Q2: What are the primary factors driving the India CGM Devices Market?
Answer: The market is primarily driven by the rising prevalence of diabetes (affecting over 100 million individuals in India), a shift toward proactive and home-based health management, the integration of CGMs with telemedicine, and local manufacturing boosts under the "Make in India" initiative.
Q3: Which region holds the largest share in the India CGM Devices Market?
Answer: North India currently dominates the market. This is largely due to the region's high prevalence of diabetes, greater awareness of proactive disease management, and highly advanced healthcare infrastructure in metro areas like Delhi-NCR.
Q4: What are the top emerging trends in the India CGM Devices Market?
Answer: Key trends include the rapid integration of CGM devices with smartphones and cloud platforms for remote monitoring, advancements in minimally invasive and longer-lasting sensors, and the growing popularity of integrated "closed-loop" CGM-insulin pump systems.
Q5: Which component segment accounts for the highest revenue in the market?
Answer: The "Sensors" segment dominates the market. Unlike durable components like transmitters and receivers, sensors have a limited lifespan (usually 7 to 14 days) and require routine replacement, leading to consistent, recurring revenue generation.
Comments